Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2019 Filed May 24, 2019 08:41 UTC |
Lanning Mark RDirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032558 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,434 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:36 UTC |
WHITE ROBERT S.Director
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032552 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,034 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:38 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032554 · doc4.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,234 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:43 UTC |
JOHNSON B KRISTINEDirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032564 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,670 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:45 UTC |
GROVES REGINA EDirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032570 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,170 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 12:48 UTC |
Drake Scott WilliamDirector
|
GrantCommon Stock | 4,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032577 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,234 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| April 30, 2019 Filed May 1, 2019 11:05 UTC |
Wade M. AndrewSVP and CFO
|
SaleCommon Stock | 9,850 | $30.00 | $295,500.00 |
DisclosureSEC source: 0001209191-19-026695 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,824 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| April 30, 2019 Filed May 2, 2019 11:02 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.30 | $0.00 |
DisclosureSEC source: 0001209191-19-026889 · doc4.xml · derivative · entry 3 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 15,000 shares Expires 2024-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on January 6, 2014 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| April 30, 2019 Filed May 2, 2019 11:02 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 15,000 | $30.00 | $450,000.00 |
DisclosureSEC source: 0001209191-19-026889 · doc4.xml · nonDerivative · entry 2 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,068 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.04 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 30, 2019 Filed May 2, 2019 11:02 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Exercise / conversionCommon Stock | 15,000 | $18.30 | $274,500.00 |
DisclosureSEC source: 0001209191-19-026889 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 20:53 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 12,569 | $27.64 | $347,407.16 |
DisclosureSEC source: 0001209191-19-024778 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,068 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.40 to $27.98 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 06:51 UTC |
Lanning Mark RDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001209191-19-022122 · doc4.xml · derivative · entry 3 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 21, 2009 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 06:51 UTC |
Lanning Mark RDirector
|
Exercise / conversionCommon Stock | 10,000 | $2.58 | $25,800.00 |
DisclosureSEC source: 0001209191-19-022122 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 07:03 UTC |
Collar Mark ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.58 | $0.00 |
DisclosureSEC source: 0001209191-19-019579 · doc4.xml · derivative · entry 3 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 10,000 shares Expires 2019-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 21, 2009 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 07:03 UTC |
Collar Mark ADirector
|
Exercise / conversionCommon Stock | 10,000 | $2.58 | $25,800.00 |
DisclosureSEC source: 0001209191-19-019579 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2019 Filed Feb 12, 2021 21:35 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 3,500 | $29.25 | $102,375.00 |
DisclosureSEC source: 0001209191-21-010168 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by spouse Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $29.15 to $29.37 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein. Read SEC document |
| March 06, 2019 Filed Feb 12, 2021 21:35 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 7,500 | $29.25 | $219,375.00 |
DisclosureSEC source: 0001209191-21-010168 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,439 F1 · price: This transaction was executed in multiple trades at prices ranging from $29.15 to $29.37 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:16 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Tax withholdingCommon Stock | 18,845 | $30.77 | $579,860.65 |
DisclosureSEC source: 0001209191-19-017223 · doc4.xml · nonDerivative · entry 2 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,637 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:16 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GrantCommon Stock | 10,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017223 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,482 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:07 UTC |
Privitera SalvatoreChief Technology Officer
|
Tax withholdingCommon Stock | 3,212 | $30.77 | $98,833.24 |
DisclosureSEC source: 0001209191-19-017217 · doc4.xml · nonDerivative · entry 2 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,910 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:07 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 10,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017217 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,122 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:05 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
Tax withholdingCommon Stock | 114,353 | $30.77 | $3,518,641.81 |
DisclosureSEC source: 0001209191-19-017215 · doc4.xml · nonDerivative · entry 2 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,668 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:05 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 38,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017215 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,021 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:14 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 20,550 | $30.77 | $632,323.50 |
DisclosureSEC source: 0001209191-19-017221 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,674 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:14 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 15,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017221 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,224 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:11 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 24,482 | $30.77 | $753,311.14 |
DisclosureSEC source: 0001209191-19-017219 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,350 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:11 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 17,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017219 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,832 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:04 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GiftCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011172 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,022 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| January 28, 2019 Filed Jan 28, 2019 21:07 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-19-005508 · doc4.xml · derivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2019-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on February 10, 2009. The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 28, 2019 Filed Jan 28, 2019 21:07 UTC |
Wade M. AndrewSVP and CFO
|
Exercise / conversionCommon Stock | 1,000 | $1.50 | $1,500.00 |
DisclosureSEC source: 0001209191-19-005508 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2019 Filed Jan 17, 2019 21:07 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GiftCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004181 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,342 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:50 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 296 | $24.00 | $7,104.00 |
DisclosureSEC source: 0001209191-19-000614 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,092 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:53 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 417 | $24.00 | $10,008.00 |
DisclosureSEC source: 0001209191-19-000622 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,787 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:52 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 252 | $24.00 | $6,048.00 |
DisclosureSEC source: 0001209191-19-000621 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,958 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:51 UTC |
Privitera SalvatoreChief Technology Officer
|
GrantCommon Stock | 732 | $24.00 | $17,568.00 |
DisclosureSEC source: 0001209191-19-000618 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,560 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 11:54 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
SaleCommon Stock | 4,000 | $30.32 | $121,280.00 |
DisclosureSEC source: 0001209191-18-047250 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,920 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.07 to $30.84 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 12:35 UTC |
Privitera SalvatoreChief Technology Officer
|
Tax withholdingCommon Stock | 4,346 | $28.49 | $123,817.54 |
DisclosureSEC source: 0001209191-18-043987 · doc4.xml · nonDerivative · entry 1 Privitera Salvatore · CIK 0001336063 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,828 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 21:08 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 900 | $15.70 | $14,130.00 |
DisclosureSEC source: 0001209191-18-041185 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,796 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2018, which was the first trading day of the applicable offering period. The closing price on January 2, 2018 was $18.47. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 21:18 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 613 | $15.70 | $9,624.10 |
DisclosureSEC source: 0001209191-18-041217 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,370 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2018, which was the first trading day of the applicable offering period. The closing price on January 2, 2018 was $18.47. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 21:13 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 967 | $15.70 | $15,181.90 |
DisclosureSEC source: 0001209191-18-041204 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,706 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2018, which was the first trading day of the applicable offering period. The closing price on January 2, 2018 was $18.47. Read SEC document |
| June 14, 2018 Filed Jun 18, 2018 06:28 UTC |
Collar Mark ADirector
|
SaleCommon Stock | 2,090 | $25.00 | $52,250.00 |
DisclosureSEC source: 0001209191-18-038220 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,898 F1 · price: The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:30 UTC |
JOHNSON B KRISTINEDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034690 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,462 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:23 UTC |
GROVES REGINA EDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034682 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,962 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:17 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034664 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,920 F1 · price: No consideration was received in connection with this gift to charity. Read SEC document |
| May 22, 2018 Filed May 24, 2018 16:27 UTC |
Collar Mark ADirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032975 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,988 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 16:40 UTC |
Lanning Mark RDirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033000 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,226 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:37 UTC |
JOHNSON B KRISTINEDirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032993 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,190 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:43 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033005 · doc4.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,026 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:46 UTC |
WHITE ROBERT S.Director
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033007 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:34 UTC |
GROVES REGINA EDirector
|
GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032989 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.